BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37376177)

  • 1. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
    Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
    Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
    Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
    Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population.
    Wargenau M; Reidemeister S; Klingmann I; Klingmann V
    Ther Innov Regul Sci; 2022 Nov; 56(6):903-909. PubMed ID: 35471561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
    Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
    Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young patients' involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms.
    Reidemeister S; Nafria Escalera B; Marín D; Balayla J; Klingmann I; Klingmann V
    Res Involv Engagem; 2023 Nov; 9(1):108. PubMed ID: 38031172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
    Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
    Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
    Klingmann V
    AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of pediatric and adult formulations of etravirine and swallowability of the 200-mg tablet: results from three Phase 1 studies.
    Kakuda TN; Berckmans C; De Smedt G; Leemans R; Leopold L; Peeters M; Nijs S; Vyncke V; van Solingen-Ristea R; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):725-37. PubMed ID: 23924679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
    Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
    Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
    Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
    Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
    Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial.
    Klingmann V; Seitz A; Meissner T; Breitkreutz J; Moeltner A; Bosse HM
    J Pediatr; 2015 Oct; 167(4):893-896.e2. PubMed ID: 26259675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing methodology to evaluate the oral sensory features of pharmaceutical tablet coatings.
    Hofmanová JK; Rajabi-Siahboomi A; Haque S; Mason J; Teckoe J; To D; Batchelor HK
    Int J Pharm; 2019 May; 562():212-217. PubMed ID: 30910634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).
    Bracken L; McDonough E; Ashleigh S; Wilson F; Shakeshaft J; Ohia U; Mistry P; Jones H; Kanji N; Liu F; Peak M
    BMJ Open; 2020 Oct; 10(10):e036508. PubMed ID: 33039988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
    Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
    J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.